aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
1.080
+0.065 (6.40%)
At close: Sep 16, 2025, 4:00 PM EDT
1.080
0.00 (-0.03%)
After-hours: Sep 16, 2025, 7:59 PM EDT
aTyr Pharma Market Cap
aTyr Pharma has a market cap or net worth of $105.83 million as of September 16, 2025. Its market cap has decreased by -26.15% in one year.
Market Cap
105.83M
Enterprise Value
38.16M
1-Year Change
-26.15%
Ranking
Category
Stock Price
1.08
Market Cap Chart
Since May 7, 2015, aTyr Pharma's market cap has decreased from $337.10M to $105.83M, a decrease of -68.61%. That is a compound annual growth rate of -10.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 105.80M | -65.19% |
| Dec 31, 2024 | 303.90M | 267.92% |
| Dec 29, 2023 | 82.60M | 30.08% |
| Dec 30, 2022 | 63.50M | -69.41% |
| Dec 31, 2021 | 207.60M | 428.24% |
| Dec 31, 2020 | 39.30M | 142.59% |
| Dec 31, 2019 | 16.20M | 8.72% |
| Dec 31, 2018 | 14.90M | -85.70% |
| Dec 29, 2017 | 104.20M | 104.31% |
| Dec 30, 2016 | 51.00M | -78.06% |
| Dec 31, 2015 | 232.50M | -31.03% |
| May 7, 2015 | 337.10M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |